You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Guidelines & Advice
About Guidelines Email Guidelines Team

The Utility of PET/CT in Breast Cancer (Stages II-IV): An Evidence Summary

ID: PET ES-14 Jan 2014
Type of Content: Guidelines & Advice, Evidence Summary
Document Status: Current
Authors:
S. Kellett, U. Metser, D. Langer, Ontario PET Steering Committee

Guideline Objective

At the request of the Ontario PET Steering Committee, literature pertaining to the utility of PET/CT in the clinical management of patients with breast cancer (stages II-IV) including inflammatory breast cancer was summarized.

Patient Population

Patients with breast cancer (stages II-IV) including inflammatory breast cancer.

Intended Guideline Users

To guide the Ontario PET Steering Committee in their decision making concerning indications for the use of PET imaging. This evidence summary may also be useful in informing clinical decision making regarding the appropriate role of PET imaging and in guiding priorities for future PET imaging research.

Research Question(s)

In patients with breast cancer (stages II-IV), does the addition of positron emission tomography/computed tomography (PET/CT) impact clinical management at initial staging when compared to conventional practices?

pdf download Full Report (PDF) (134.25 KB)